↓ Skip to main content

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

Overview of attention for article published in Infectious Diseases of Poverty, April 2023
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Published in
Infectious Diseases of Poverty, April 2023
DOI 10.1186/s40249-023-01092-1
Pubmed ID
Authors

Aziz Rezapour, Zahra Behroozi, Mostafa Nasirzadeh, Mohsen Rezaeian, Mohammad Barzegar, Mahsa Tashakori-Miyanroudi, Abdollah Sayyad, Aghdas Souresrafil

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 17%
Researcher 4 13%
Unspecified 3 10%
Student > Ph. D. Student 3 10%
Librarian 1 3%
Other 2 7%
Unknown 12 40%
Readers by discipline Count As %
Nursing and Health Professions 4 13%
Unspecified 3 10%
Pharmacology, Toxicology and Pharmaceutical Science 3 10%
Biochemistry, Genetics and Molecular Biology 2 7%
Business, Management and Accounting 1 3%
Other 5 17%
Unknown 12 40%